Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015: A systematic review and meta-analysis

BACKGROUND: Myocardial Infarction (MI) has become a major cause of morbidity and mortality in China, but little is known about the prevalence of guideline-recommended cardiovascular medications after MI events over the last two decades. This systematic review and meta-analysis aims to summarize card...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Min, Klipstein-Grobusch, Kerstin, Wang, Xin, Reitsma, Johannes B., Zhao, Dong, Grobbee, Diederick E., Graham, Ian, Vaartjes, Ilonca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398555/
https://www.ncbi.nlm.nih.gov/pubmed/28426793
http://dx.doi.org/10.1371/journal.pone.0175947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398555/
https://www.ncbi.nlm.nih.gov/pubmed/28426793
http://dx.doi.org/10.1371/journal.pone.0175947

Ejemplares similares